BSEGeneral3h ago · 3 Oct 2026, 05:32 pm
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Transgene Biotek Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L85195TG1990PLC011065</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December, as applicable ....
Transgene Biotek Ltd · 526139
✦ AI SummaryRegulatory
Transgene Biotek Ltd has confirmed that it does not fall under the category of 'Large Corporate' as per SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, and BSE Circular No. LIST/COM/05/2019-20 dated April 11, 2019.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Transgene Biotek Ltd - 526139 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Attachments (1)
📄pdf
Download →
1d21225a-3faa-48b5-a843-91656d82d724.pdf
View document text
Date: 03-10-2026
The General Manager
Listing Compliance Department
BSE Limited
Phiroze Jeejeebhoy Towers
Dalal Street, Mumbai – 400 001
Ref: - Scrip Code/ SYMBOL: 526139
Dear Sir / Madam,
Subject: Confirmation regarding not falling under Large Corporate criteria
pursuant to SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated
November 26, 2018 and BSE Circular No. LIST/COM/05/2019-20 dated April
11, 2019
Pursuant to SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26,
2018, relating to fund raising by issuance of debt securities by Large Corporates, and
BSE Circular No. LIST/COM/05/2019-20 dated April 11, 2019, we hereby confirm that
Transgene Biotek Limited does not fulfil the criteria specified in Para 2.2 of the aforesaid
SEBI Circular and, accordingly, the Company does not fall under the category of “Large
Corporate” as defined under the said Circular.
The Company therefore confirms that the provisions applicable to Large Corporates
under the aforesaid SEBI Circular are not applicable to the Company.
We kindly request you to take the same on record.
Thanking you
Yours Sincerely
For TRANSGENE BIOTEK LIMITED
DR K KOTESWARA RAO
CHAIRMAN & MANAGING DIRECTOR
DIN: 02287235
Plot 69 & 70, IDA Bollaram, Sangareddy District – 502 325, Telangana, India
Ph: +91-40-65589499 Fax: +91-8458-279755 Web: www.transgenebiotek.com
Email: info@transgenebiotek.com, CIN No: L85195AP1990PLC011065